Search research articles
Contact Us
Filters
Showing results (151-160 of 253) with videos related to
Page
of 26
Sort By:
JAMA Psychiatry
|
March 8, 2023
Prevalence of Perinatal Depression in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
Alexandra Roddy Mitchell, Hannah Gordon, Anthea Lindquist, et al.
Placenta
|
November 23, 2016
Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta
Louie Ye, Amy Gratton, Natalie J Hannan, et al.
Pregnancy Hypertension
|
March 22, 2020
Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction
Natasha de Alwis, Sally Beard, Yeukai T Mangwiro, et al.
Ebiomedicine
|
February 13, 2018
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy
Roxanne Hastie, Elgene Lim, Pavel Sluka, et al.
Human Reproduction (Oxford, England)
|
May 13, 2023
Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy
Scott C Mackenzie, Catherine A Moakes, Ann M Doust, et al.
Obstetrics and Gynecology
|
October 3, 2013
Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy
Monika M Skubisz, Andrew W Horne, Terrance G Johns, et al.
Diabetes Care
|
September 3, 2025
Maternal Diabetes, Fetal Growth and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia
Hannah G Gordon, Alexis Shub, Susan P Walker, et al.
Scientific Reports
|
May 14, 2017
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment
Natalie J Hannan, Fiona C Brownfoot, Ping Cannon, et al.
Plos One
|
February 22, 2018
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia
Tu'uhevaha J Kaitu'u-Lino, Fiona C Brownfoot, Sally Beard, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 27, 2017
Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta
Tu'uhevaha J Kaitu'u-Lino, Fiona C Brownfoot, Roxanne Hastie, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 253) with videos related to
Sort By:
Page
of 26
JAMA Psychiatry
|
March 8, 2023
Prevalence of Perinatal Depression in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
Alexandra Roddy Mitchell, Hannah Gordon, Anthea Lindquist, et al.
Placenta
|
November 23, 2016
Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta
Louie Ye, Amy Gratton, Natalie J Hannan, et al.
Pregnancy Hypertension
|
March 22, 2020
Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction
Natasha de Alwis, Sally Beard, Yeukai T Mangwiro, et al.
Ebiomedicine
|
February 13, 2018
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy
Roxanne Hastie, Elgene Lim, Pavel Sluka, et al.
Human Reproduction (Oxford, England)
|
May 13, 2023
Early (Days 1-4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy
Scott C Mackenzie, Catherine A Moakes, Ann M Doust, et al.
Obstetrics and Gynecology
|
October 3, 2013
Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy
Monika M Skubisz, Andrew W Horne, Terrance G Johns, et al.
Diabetes Care
|
September 3, 2025
Maternal Diabetes, Fetal Growth and Stillbirth Risk: A Population-Wide Retrospective Cohort Study From Victoria, Australia
Hannah G Gordon, Alexis Shub, Susan P Walker, et al.
Scientific Reports
|
May 14, 2017
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment
Natalie J Hannan, Fiona C Brownfoot, Ping Cannon, et al.
Plos One
|
February 22, 2018
Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia
Tu'uhevaha J Kaitu'u-Lino, Fiona C Brownfoot, Sally Beard, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 27, 2017
Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta
Tu'uhevaha J Kaitu'u-Lino, Fiona C Brownfoot, Roxanne Hastie, et al.
Page
of 26